These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12714585)
1. Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival. Lee HY; Srinivas H; Xia D; Lu Y; Superty R; LaPushin R; Gomez-Manzano C; Gal AM; Walsh GL; Force T; Ueki K; Mills GB; Kurie JM J Biol Chem; 2003 Jun; 278(26):23630-8. PubMed ID: 12714585 [TBL] [Abstract][Full Text] [Related]
2. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer. Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952 [TBL] [Abstract][Full Text] [Related]
3. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. Chuang SM; Wang IC; Yang JL Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022 [TBL] [Abstract][Full Text] [Related]
4. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Kandasamy K; Srivastava RK Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743 [TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. Xia D; Srinivas H; Ahn YH; Sethi G; Sheng X; Yung WK; Xia Q; Chiao PJ; Kim H; Brown PH; Wistuba II; Aggarwal BB; Kurie JM J Biol Chem; 2007 Feb; 282(6):3507-19. PubMed ID: 17158870 [TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. Gu J; Tamura M; Yamada KM J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564 [TBL] [Abstract][Full Text] [Related]
7. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway. Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851 [TBL] [Abstract][Full Text] [Related]
8. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Okumura K; Shirasawa S; Nishioka M; Sasazuki T Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756 [TBL] [Abstract][Full Text] [Related]
9. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732 [TBL] [Abstract][Full Text] [Related]
10. G(i)-dependent activation of c-Jun N-terminal kinase in human embryonal kidney 293 cells. Yamauchi J; Kawano T; Nagao M; Kaziro Y; Itoh H J Biol Chem; 2000 Mar; 275(11):7633-40. PubMed ID: 10713072 [TBL] [Abstract][Full Text] [Related]
11. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640 [TBL] [Abstract][Full Text] [Related]
12. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
13. Zn(2+) induces stimulation of the c-Jun N-terminal kinase signaling pathway through phosphoinositide 3-Kinase. Eom SJ; Kim EY; Lee JE; Kang HJ; Shim J; Kim SU; Gwag BJ; Choi EJ Mol Pharmacol; 2001 May; 59(5):981-6. PubMed ID: 11306679 [TBL] [Abstract][Full Text] [Related]
14. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. Kunz M; Ibrahim S; Koczan D; Thiesen HJ; Köhler HJ; Acker T; Plate KH; Ludwig S; Rapp UR; Bröcker EB; van Muijen GN; Flory E; Gross G Cell Growth Differ; 2001 Mar; 12(3):137-45. PubMed ID: 11306514 [TBL] [Abstract][Full Text] [Related]
15. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Yu W; Liao QY; Hantash FM; Sanders BG; Kline K Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656 [TBL] [Abstract][Full Text] [Related]
16. Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis. Skov S; Klausen P; Claesson MH J Cell Biol; 1997 Dec; 139(6):1523-31. PubMed ID: 9396757 [TBL] [Abstract][Full Text] [Related]
17. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Weng LP; Brown JL; Baker KM; Ostrowski MC; Eng C Hum Mol Genet; 2002 Jul; 11(15):1687-96. PubMed ID: 12095911 [TBL] [Abstract][Full Text] [Related]
18. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells. Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820 [TBL] [Abstract][Full Text] [Related]
19. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]